GSK: Ethics Issues
-
Upload
francine-zachary-kwan -
Category
Business
-
view
371 -
download
1
description
Transcript of GSK: Ethics Issues
![Page 1: GSK: Ethics Issues](https://reader035.fdocuments.in/reader035/viewer/2022080209/547d1717b4af9fea158b5301/html5/thumbnails/1.jpg)
Prepared by:
Adriana Cusniriuc, Alice Hoey, Crystalle
Liceralde, Francine Kwan, Monisha Andruse
GlaxoSmithKline
Business and
Professional Ethics
![Page 2: GSK: Ethics Issues](https://reader035.fdocuments.in/reader035/viewer/2022080209/547d1717b4af9fea158b5301/html5/thumbnails/2.jpg)
Background Research
GSK is one of the top pharmaceutical
manufacturers in the world.
Their offices are situated in 115 countries
including USA, Spain and China.
Spent around £4 billion in research and
development of medicines.
Few of their products include Ribena,
Lucozade, Sensodyne and Panadol.
2
![Page 3: GSK: Ethics Issues](https://reader035.fdocuments.in/reader035/viewer/2022080209/547d1717b4af9fea158b5301/html5/thumbnails/3.jpg)
GSK Controversies
Ribena
Seroxat Avandia
3
![Page 4: GSK: Ethics Issues](https://reader035.fdocuments.in/reader035/viewer/2022080209/547d1717b4af9fea158b5301/html5/thumbnails/4.jpg)
Ribena Ad.
4
![Page 5: GSK: Ethics Issues](https://reader035.fdocuments.in/reader035/viewer/2022080209/547d1717b4af9fea158b5301/html5/thumbnails/5.jpg)
Ribena Two
teenagers
discovered
the absence
of Vitamin C.
The school
girls contacted
GSK twice
without valid
response.
Fair Go
suggested to
take matters
into
commerce
commission.
Pleaded
guilty for 15
charges and
were fined
$217,500.
![Page 6: GSK: Ethics Issues](https://reader035.fdocuments.in/reader035/viewer/2022080209/547d1717b4af9fea158b5301/html5/thumbnails/6.jpg)
Issues Raised
Mislead consumers in the context of Vitamin C
Shows lack of business ethics
Utilised incorrect information for their own
competitive advantage and to increase profit.
Acted against GSK’s Code of Ethics.
6
![Page 7: GSK: Ethics Issues](https://reader035.fdocuments.in/reader035/viewer/2022080209/547d1717b4af9fea158b5301/html5/thumbnails/7.jpg)
Avandia & Seroxat
DRUG Anti-diabetic Anti-depressant
CAUSES High risks of heart
attack
Self-harmed and/or
committed suicide
ACTIONS
TOOK
Asked doctors to hide
information on risks
concerning Avandia.
GSK hid the negative
impacts of Seroxat on
its packaging.
RESOLVED Fined $3 billion and allowed the govt. to
monitor their actions for the next 5 years.
7
![Page 8: GSK: Ethics Issues](https://reader035.fdocuments.in/reader035/viewer/2022080209/547d1717b4af9fea158b5301/html5/thumbnails/8.jpg)
Issues Raised
8
GSK broke three out of six rules in medical
ethics.
Doctors prescribed off-label drugs to patients.
The producers were aware about the extent of
harmfulness prior to disguising information.
Transactions were carried out without a valid
children’s license.
![Page 9: GSK: Ethics Issues](https://reader035.fdocuments.in/reader035/viewer/2022080209/547d1717b4af9fea158b5301/html5/thumbnails/9.jpg)
Conclusion
GSK’s actions highly contradicts with their slogan.
They lacked compassion towards families who were
affected by their products.
There should be a top governing body for preventing
mistakes happening within workforce.
Govt. should place a secondary body to asses
prescribed medicine before giving.
Concealment of dangerous information expresses an
egoistic and self-interest view of GSK.
9
![Page 10: GSK: Ethics Issues](https://reader035.fdocuments.in/reader035/viewer/2022080209/547d1717b4af9fea158b5301/html5/thumbnails/10.jpg)
10